Kim Soo Hyun, Tsao Hensin
Harvard Medical School, Boston, MA 02115, USA.
Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Biomolecules. 2025 Jan 14;15(1):120. doi: 10.3390/biom15010120.
Acral melanoma is a distinct subtype of cutaneous malignant melanoma that uniquely occurs on ultraviolet (UV)-shielded, glabrous skin of the palms, soles, and nail beds. While acral melanoma only accounts for 2-3% of all melanomas, it represents the most common subtype among darker-skinned, non-Caucasian individuals. Unlike other cutaneous melanomas, acral melanoma does not arise from UV radiation exposure and is accordingly associated with a relatively low tumor mutational burden. Recent advances in genomic, transcriptomic, and epigenomic sequencing have revealed genetic alterations unique to acral melanoma, including novel driver genes, high copy number variations, and complex chromosomal rearrangements. This review synthesizes the current knowledge on the clinical features, epidemiology, and treatment approaches for acral melanoma, with a focus on the genetic pathogenesis that gives rise to its unique tumor landscape. These findings highlight a need to deepen our genetic and molecular understanding to better target this challenging subtype of melanoma.
肢端黑色素瘤是皮肤恶性黑色素瘤的一种独特亚型,它仅发生在手掌、足底和甲床等免受紫外线(UV)照射的无毛皮肤上。虽然肢端黑色素瘤仅占所有黑色素瘤的2%-3%,但它却是深色皮肤的非白种人个体中最常见的亚型。与其他皮肤黑色素瘤不同,肢端黑色素瘤并非由紫外线辐射暴露引起,因此其肿瘤突变负荷相对较低。基因组、转录组和表观基因组测序的最新进展揭示了肢端黑色素瘤特有的基因改变,包括新的驱动基因、高拷贝数变异和复杂的染色体重排。本综述综合了目前关于肢端黑色素瘤的临床特征、流行病学和治疗方法的知识,重点关注导致其独特肿瘤格局的遗传发病机制。这些发现凸显了加深我们对其遗传和分子理解的必要性,以便更好地针对这种具有挑战性的黑色素瘤亚型。